Autor był koordynatorem na Polskę i członkiem Steering Committee badania Q-SYMBIO; pobierał honoraria wykładowe za prelekcje dotyczące koenzymu Q10.
Piśmiennictwo
1. Mortensen SA, Rosenfeldt F, Kumar A, et al. for Q-SYMBIO Study Investigators. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2014;2(6):641-9. doi: 10.1016/j.jchf.2014.06.008
2. Mortensen AL, Rosenfeldt F, Filipiak KJ. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial. Cardiol J 2019;26(2):147-56. doi: 10.5603/CJ.a2019.0022
3. Alehagen U, Johansson P, Björnstedt M, et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol 2013;167(5):1860-6. doi: 10.1016/j.ijcard.2012.04.156